- Home
- KYMR vs DFH Comparison
KYMR vs DFH Comparison
Compare KYMR & DFH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- DFH
- Stock Information
- Founded
- KYMR 2015
- DFH 2008
- Country
- KYMR United States
- DFH United States
- Employees
- KYMR N/A
- DFH N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- DFH Homebuilding
- Sector
- KYMR Health Care
- DFH Consumer Discretionary
- Exchange
- KYMR Nasdaq
- DFH Nasdaq
- Market Cap
- KYMR 3.1B
- DFH 2.6B
- IPO Year
- KYMR 2020
- DFH 2021
- Fundamental
- Price
- KYMR $47.28
- DFH $28.76
- Analyst Decision
- KYMR Strong Buy
- DFH Hold
- Analyst Count
- KYMR 15
- DFH 1
- Target Price
- KYMR $58.53
- DFH $28.00
- AVG Volume (30 Days)
- KYMR 599.5K
- DFH 315.3K
- Earning Date
- KYMR 10-30-2025
- DFH 10-30-2025
- Dividend Yield
- KYMR N/A
- DFH N/A
- EPS Growth
- KYMR N/A
- DFH 0.34
- EPS
- KYMR N/A
- DFH 3.08
- Revenue
- KYMR $44,711,000.00
- DFH $4,708,435,000.00
- Revenue This Year
- KYMR $58.45
- DFH $6.07
- Revenue Next Year
- KYMR N/A
- DFH $1.25
- P/E Ratio
- KYMR N/A
- DFH $9.32
- Revenue Growth
- KYMR N/A
- DFH 20.19
- 52 Week Low
- KYMR $19.45
- DFH $19.65
- 52 Week High
- KYMR $53.27
- DFH $39.15
- Technical
- Relative Strength Index (RSI)
- KYMR 64.57
- DFH 51.77
- Support Level
- KYMR $42.71
- DFH $28.82
- Resistance Level
- KYMR $44.43
- DFH $31.02
- Average True Range (ATR)
- KYMR 1.98
- DFH 1.16
- MACD
- KYMR 0.60
- DFH -0.04
- Stochastic Oscillator
- KYMR 91.51
- DFH 42.29
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About DFH Dream Finders Homes Inc.
Dream Finders Homes Inc is engaged in the home building business. The company's primary focus is on constructing and selling single-family homes across entry-level, first-time move-up, second-time move-up, and active adult markets. Its homebuilding operations are organized into four reportable segments: Southeast, Mid-Atlantic, Midwest, and Financial Services. It generates the majority of its revenue from the Midwest segment.